Cormorant Private Healthcare Fund II, LP (CIK 0001747677)

Latest company ownership

ERAS - Erasca, Inc.
Role: Director
Shares held
11,019,912
Last filed at
Jun 26, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
Shares held
2,214,545
Last filed at
Jun 18, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4
Shares held
1,994,173
Last filed at
Oct 1, 2025
Confidence Score
43.4
2025Q4
Confidence Score History
2023Q4 2025Q4
Shares held
1,530,691
Last filed at
Jul 7, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q3 2025Q4
BCAB - BioAtla, Inc.
Role: 10% Owner
Shares held
1,492,060
Last filed at
Dec 22, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
1,404,953
Last filed at
Apr 1, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q1 2025Q4
Shares held
723,177
Last filed at
Nov 23, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q4 2025Q4
Shares held
477,857
Last filed at
Jun 30, 2021
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Sep 29, 2025 Oct 1, 2025 MoonLake Immunotherapeutics Other Sell 15.0 -6,499,978 -76.52% ✗ $46.9M
Oct 5, 2023 Oct 10, 2023 MoonLake Immunotherapeutics 10% Owner Buy 77.5 +58,839 0.70% ✗ $3.5M
Oct 2, 2023 Oct 4, 2023 MoonLake Immunotherapeutics 10% Owner Buy 95.0 +293,212 3.60% ✗ $16.8M
Dec 13, 2022 Dec 21, 2022 Erasca, Inc. Director Buy 92.5 +307,692 2.93% ✗ $2M
Dec 13, 2022 Dec 20, 2022 Erasca, Inc. Director Buy 92.5 +307,692 2.93% ✗ $2M
Jul 20, 2021 Jul 22, 2021 Erasca, Inc. 10% Owner Buy 97.5 +950,000 9.94% ✗ $15.2M
Jul 2, 2021 Jul 7, 2021 Jade Biosciences, Inc. Other Buy 100.0 +500,000 32.66% ✗ $7M
Jun 28, 2021 Jun 30, 2021 Monte Rosa Therapeutics, Inc. 10% Owner Buy 100.0 +600,000 23.06% ✗ $11.4M
Mar 30, 2021 Apr 1, 2021 Design Therapeutics, Inc. Other Buy 100.0 +750,000 17.18% ✗ $15M
Dec 18, 2020 Dec 22, 2020 BioAtla, Inc. 10% Owner Buy 100.0 +800,000 53.62% ✗ $14.4M
Nov 23, 2020 Nov 23, 2020 Olema Pharmaceuticals, Inc. 10% Owner Buy 100.0 +425,000 14.94% ✗ $8.1M
Jun 16, 2020 Jun 18, 2020 Avidity Biosciences, Inc. 10% Owner Buy 100.0 +300,000 13.55% ✗ $5.4M